ACKERMAN JOEL 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Nov 7, 2025
Insider Transaction Report
Form 4
ACKERMAN JOEL
DirectorChief Executive Officer
Transactions
- Award
Option to purchase Common Stock
2025-11-05$6.80/sh+21,216$144,269→ 21,216 totalExercise: $6.80Exp: 2035-11-05→ Common Stock (21,216 underlying)
Footnotes (1)
- [F1]The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.